drugset / Trial / NCT00183339

Early Intervention With Fluoxetine in Autism

NCT00183339

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a pilot study to evaluate the feasibility and safety of conducting a year long, double-blind, placebo-controlled trial of fluoxetine in pre-school children to enhance developmental processes in core areas impacted by autism.

Timeline

Start
2005-07
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule

Indications